The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum
Abstract
Well-differentiated neuroendocrine tumors (NETs) of the jejunum, ileum, and appendix are also collectively known as midgut carcinoids. Similar to NETs in general, the diagnosed incidence of the midgut NETs is on the rise. Their presenting symptoms vary depending on stage and primary site. Local-regional NETs often present with vague and nonspecific symptoms. Classic carcinoid syndrome is more likely to appear in patients with advanced disease. Local-regional NETs of the small bowel should be resected whenever possible. With the exception of small well-differentiated NETs of the appendix, NETs of the midgut have substantial risk of relapse after resection and need to be followed for at least 7 years.Metastatic/advanced NETs of the midgut are incurable. Optimal management requires a multidisciplinary approach. Somatostatin analogs are effective in the management of carcinoid syndrome. Octreotide long-acting release has also recently been shown to delay disease progression. Liver-directed therapy and surgical debulking can improve quality of life in selected patients. Pivotal phase 3 studies with bevacizumab targeting vascular endothelial growth factor and everolimus targeting mTOR (mammalian target of rapamycin) are ongoing and may lead to improved outcome. Further studies of novel approaches such as peptide receptor radiotherapy are also warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Self-citationA 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Yao, J. C., Phan, A. T., Chang, D. Z., Wolff, R. A., Hess, K., Gupta, S., Jacobs, C., Mares, J. E., Landgraf, A. N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7858 · Cited by 649
Self-citationLife history of the carcinoid tumor of the small intestine
Moertel, C. G., Sauer, W. G., Dockerty, M. B., & Baggenstoss, A. H. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q · Cited by 555
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Self-citationGupta, S., Johnson, M. M., Murthy, R., Ahrar, K., Wallace, M. J., Madoff, D. C., McRae, S. E., Hicks, M. E., Rao, S., Vauthey, J., et al. (2005) · Cancer · doi:10.1002/cncr.21389 · Cited by 433
Self-citationYao, J. C., Phan, A., Hoff, P. M., Chen, H. X., Charnsangavej, C., Yeung, S.-C. J., Hess, K., Ng, C., Abbruzzese, J. L., & Ajani, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6374 · Cited by 414
Self-citationRubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Tang, L. H., Shia, J., Soslow, R. A., Dhall, D., Wong, W. D., O'Reilly, E., Qin, J., Paty, P., Weiser, M. R., Guillem, J., et al. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817f1816 · Cited by 345
Self-citationOrlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
KRENNING, E. P., KOOIJ, P. P. M., BAKKER, W. H., BREEMAN, W. A. P., POSTEMA, P. T. E., KWEKKEBOOM, D. J., OEI, H. Y., de JONG, M., VISSER, T. J., REIJS, A. E. M., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17300.x · Cited by 313
Bajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E., & Bombardieri, E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990901)86:5<858::aid-cncr23>3.0.co;2-8 · Cited by 289
Perianesthetic Risks and Outcomes of Pheochromocytoma and Paraganglioma Resection
Kinney, M. A. O., Warner, M. E., vanHeerden, J. A., Horlocker, T. T., Young, W. F., Schroeder, D. R., Maxson, P. M., & Warner, M. A. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200011000-00013 · Cited by 252
Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid
Feldman, J., & Lee, E. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/42.4.639 · Cited by 219
Neuroendocrine tumors of the pancreas: Spectrum of appearances on MRI
Semelka, R. C., Custodio, C. M., Balci, N. C., & Woosley, J. T. (2000) · Journal of Magnetic Resonance Imaging · Cited by 197
Carcinoid A Comprehensive Review
Schnirer, I. I., Yao, J. C., & Ajani, J. A. (2003) · Acta Oncologica · doi:10.1080/02841860310010547 · Cited by 192
Self-citationLee, C., Lu, S., Changchien, C., Yeh, C., Tt, H., Tang, J., Wang, J.-H., Lin, D., Chen, C., & Chen, W. J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991001)86:7<1377::aid-cncr38>3.0.co;2-7 · Cited by 187
Vogl, T. J., Naguib, N. N. N., Zangos, S., Eichler, K., Hedayati, A., & Nour-Eldin, N.-E. A. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.08.008 · Cited by 180
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours
Nehar, D., Lombard‐Bohas, C., Olivieri, S., Claustrat, B., Chayvialle, J., Penes, M., Sassolas, G., & Borson‐Chazot, F. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02030.x · Cited by 177
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours
Öberg, K. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s111 · Cited by 167
Choi, I.-S., Estecio, M. R. H., Nagano, Y., Kim, D. H., White, J. A., Yao, J. C., Issa, J.-P. J., & Rashid, A. (2007) · Modern Pathology · doi:10.1038/modpathol.3800825 · Cited by 161
Self-citationProcedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.
Balon, H. R., Goldsmith, S. J., Siegel, B. A., Silberstein, E. B., Krenning, E. P., Lang, O., & Donohoe, K. J. (2001) · PubMed · Cited by 140
Self-citationRisk factors for small intestine cancer
Chow, W. H., Linet, M. S., McLaughlin, J. K., Hsing, A. W., Chien, H. T. C., & Blot, W. J. (1993) · Cancer Causes & Control · doi:10.1007/bf00053158 · Cited by 139
Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
Janson, E. T., Ahlström, H. K., Andersson, T., & Öberg, K. E. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90060-f · Cited by 130
Prospective Study of Dietary Fiber, Whole Grain Foods, and Small Intestinal Cancer
Schatzkin, A. G., Park, Y., Leitzmann, M. F., Hollenbeck, A. R., & Cross, A. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.015 · Cited by 126
Öberg, K. (2004) · Acta Oncologica · doi:10.1080/02841860410018502 · Cited by 120
Maroun, J. A., Kocha, W., Kvols, L. K., Bjarnason, G. A., Chen, E., Germond, C. J., Hanna, S. S., Poitras, P., Rayson, D., Reid, R. H., et al. (2006) · Current Oncology · doi:10.3390/curroncol13020006 · Cited by 117
Members of Nordic Ne Tumour Group:, Öberg, K., Astrup, L. B., Eriksson, B. K., Falkmer, S. E., Falkmer, S., Gustafsen, J., Haglund, C., Knigge, U., Vatn, M. H., et al. (2004) · Acta Oncologica · doi:10.1080/02841860410018575 · Cited by 105
Imaging appearances of metastases from neuroendocrine tumours of the pancreas
Debray, M., Geoffroy, O., Laissy, J., Lebtahi, R., Silbermann-Hoffman, O., Henry–Feugeas, M.-C., Cadiot, G., Mignon, M., & Schouman‐Claeys, E. (2001) · British Journal of Radiology · doi:10.1259/bjr.74.887.741065 · Cited by 100
The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid
Tormey, W. P., & Fitzgerald, R. J. (1995) · Postgraduate Medical Journal · doi:10.1136/pgmj.71.839.542 · Cited by 67
Hassan, M. M., Phan, A. T., Li, D., Dagohoy, C. G., Leary, C. C., & Yao, J. C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0750 · Cited by 60
Self-citationA Prospective Study of Meat and Fat Intake in Relation to Small Intestinal Cancer
Cross, A. J., Leitzmann, M. F., Subar, A. F., Thompson, F. E., Hollenbeck, A. R., & Schatzkin, A. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2015 · Cited by 59
Biesma, B., Willemse, P., Mulder, N., Verschueren, R. C. J., Kema, I., de Bruijn, H. W. A., Postmus, P. E., Sleijfer, D., & de Vries, E. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.372 · Cited by 59
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
BERNINI, G. P., Moretti, A., Ferdeghini, M., Ricci, S., Letizia, C., D'Erasmo, E., Argenio, G. F., & Salvetti, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1659 · Cited by 56
Biotherapy for metastatic endocrine tumours
Shah, T., & Caplin, M. E. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.012 · Cited by 55
Self-citationKærlev, L., Teglbjaerg, P. S., Sabroe, S., Kolstad, H. A., Ahrens, W., Eriksson, M., Guénel, P., Gorini, G., Hardell, L., Cyr, D., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1013922226614 · Cited by 48
Ishii, E., Kimura, N., Kato, K., Sako, M., Nagano, M., Nakagawa, A., Okamura, T., Yamaguchi, H., Kawa, K., & Hara, T. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990401)85:7<1470::aid-cncr7>3.0.co;2-s · Cited by 17
Development of Isolated Hepatic Perfusion for Patients Who Have Unresectable Hepatic Malignancies
Jones, A., & Alexander, H. R. (2008) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2008.04.011 · Cited by 14
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
(1993) · doi:10.1002/1097-0142(19931115)72:10 · Cited by 1
Cited by
Gastroenteropancreatic Neuroendocrine Tumors
Cives, M., & Strosberg, J. R. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21493 · Cited by 586
Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
Kunz, P. L., Reidy-Lagunes, D., Anthony, L. B., Bertino, E. M., Brendtro, K., Chan, J. A., Chen, H., Jensen, R. T., Kim, M. K., Klimstra, D. S., et al. (2013) · Pancreas · doi:10.1097/mpa.0b013e31828e34a4 · Cited by 580
Self-citationENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Pape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Howe, J. R., Cardona, K., Fraker, D. L., Kebebew, E., Untch, B. R., Wang, Y.-Z., Law, C. H., Liu, E. H., Kim, M. K., Menda, Y., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000846 · Cited by 376
Metadata
- Authors
- Boudreaux, J. P., Klimstra, D. S., Hassan, M. M., Woltering, E. A., Jensen, R. T., Goldsmith, S. J., Nutting, C., Bushnell, D. L., Caplin, M. E., & Yao, J. C.
- Venue
- Pancreas
- Published
- 2010-08
- Volume
- 39
- Issue
- 6
- Pages
- 753-766
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2128669850
- Cited by
- 539
- References
- 40
- FWCI
- 17.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.